CYTRX CORP
10-Q, EX-27.1, 2000-08-10
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: CYTRX CORP, 10-Q, 2000-08-10
Next: CYTRX CORP, 10-Q, EX-27.2, 2000-08-10



<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5

<S>                             <C>                     <C>
<PERIOD-TYPE>                   3-MOS                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000             DEC-31-2000
<PERIOD-START>                             APR-01-2000             JAN-01-2000
<PERIOD-END>                               JUN-30-2000             JUN-30-2000
<CASH>                                       2,374,197               2,374,197
<SECURITIES>                                         0                       0
<RECEIVABLES>                                  322,121                 322,121
<ALLOWANCES>                                         0                       0
<INVENTORY>                                          0                       0
<CURRENT-ASSETS>                             2,756,269               2,756,269
<PP&E>                                       3,169,996               3,169,996
<DEPRECIATION>                                 644,887                 644,887
<TOTAL-ASSETS>                               5,992,356               5,992,356
<CURRENT-LIABILITIES>                        1,532,273               1,532,273
<BONDS>                                              0                       0
                                0                       0
                                          0                       0
<COMMON>                                        10,214                  10,214
<OTHER-SE>                                   4,449,869               4,449,869
<TOTAL-LIABILITY-AND-EQUITY>                 5,992,356               5,992,356
<SALES>                                         85,156                 185,284
<TOTAL-REVENUES>                               282,928                 633,470
<CGS>                                           44,281                  96,701
<TOTAL-COSTS>                                   44,281                  96,701
<OTHER-EXPENSES>                             1,000,763               2,238,789
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                                   0                       0
<INCOME-PRETAX>                              (762,116)             (1,702,020)
<INCOME-TAX>                                         0                       0
<INCOME-CONTINUING>                          (762,116)             (1,702,020)
<DISCONTINUED>                                 759,514                 799,328
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                                   (2,602)               (902,692)
<EPS-BASIC>                                      (.00)                   (.10)
<EPS-DILUTED>                                    (.00)                   (.10)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission